11-1291476-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_019009.4(TOLLIP):c.184-1067G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 150,258 control chromosomes in the GnomAD database, including 1,480 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance,association (no stars).
Frequency
Genomes: 𝑓 0.12 ( 1480 hom., cov: 24)
Consequence
TOLLIP
NM_019009.4 intron
NM_019009.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0880
Genes affected
TOLLIP (HGNC:16476): (toll interacting protein) This gene encodes a ubiquitin-binding protein that interacts with several Toll-like receptor (TLR) signaling cascade components. The encoded protein regulates inflammatory signaling and is involved in interleukin-1 receptor trafficking and in the turnover of IL1R-associated kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.174 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOLLIP | NM_019009.4 | c.184-1067G>C | intron_variant | ENST00000317204.11 | NP_061882.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOLLIP | ENST00000317204.11 | c.184-1067G>C | intron_variant | 1 | NM_019009.4 | ENSP00000314733.5 |
Frequencies
GnomAD3 genomes AF: 0.123 AC: 18402AN: 150142Hom.: 1478 Cov.: 24
GnomAD3 genomes
AF:
AC:
18402
AN:
150142
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.122 AC: 18405AN: 150258Hom.: 1480 Cov.: 24 AF XY: 0.122 AC XY: 8964AN XY: 73312
GnomAD4 genome
AF:
AC:
18405
AN:
150258
Hom.:
Cov.:
24
AF XY:
AC XY:
8964
AN XY:
73312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
232
AN:
3478
ClinVar
Significance: Uncertain significance; association
Submissions summary: Uncertain:3Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Susceptibility to severe coronavirus disease (COVID-19) Uncertain:1
Uncertain significance, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 13, 2024 | The NC_000011.10:g.1291476C>G (rs111521887) is an intron variant in TOLLIP (toll interacting protein) that has been associated with idiopathic pulmonary fibrosis and other lung diseases. We evaluated this variant in 923 patients with COVID-19 and we did not find any association with mortality or severity risk. Due to the lack of association of the variant with the studied phenotypes, it was classified as uncertain significance. - |
Chronic obstructive pulmonary disease Uncertain:1
Uncertain significance, no assertion criteria provided | case-control | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 04, 2021 | - - |
Combined pulmonary fibrosis-emphysema syndrome Uncertain:1
Uncertain significance, no assertion criteria provided | case-control | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 04, 2021 | - - |
Interstitial lung disease 2 Other:1
association, no assertion criteria provided | case-control | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 04, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at